Related Experiment Video

Updated: Aug 18, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Statins and stroke

Matthias Endres1

  • 1Klinik und Poliklinik für Neurologie, Charité, Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany. Matthias.endres@charite.de

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|April 9, 2005
PubMed

Insights

Statins, HMG-CoA reductase inhibitors, offer stroke protection beyond cholesterol reduction through pleiotropic effects. Sudden discontinuation may lead to adverse vascular events.

Area of Science:

  • Cardiovascular Research
  • Neuroprotection
  • Pharmacology

Background:

  • Statins (HMG-CoA reductase inhibitors) are primary cholesterol-lowering drugs.
  • Clinical trials demonstrate statins reduce cerebrovascular events, despite cholesterol not being a primary stroke risk factor.
  • Statins possess pleiotropic, vasculoprotective actions beyond lipid reduction.

Purpose of the Study:

  • To explore the mechanisms by which statins reduce stroke incidence.
  • To investigate the role of statins' pleiotropic effects in cerebrovascular protection.
  • To examine the impact of statin discontinuation on vascular function.

Main Methods:

  • Review of large clinical trials and retrospective evidence on statin use.
  • Analysis of statins' pleiotropic effects: endothelial function, nitric oxide (NO) bioavailability, antioxidant and anti-inflammatory actions.
  • Examination of animal models of stroke and clinical data on statin withdrawal.

Main Results:

  • Statins improve endothelial function, increase NO bioavailability, and possess antioxidant/anti-inflammatory properties.
  • Statins augment cerebral blood flow and protect against stroke in animal models, partly via endothelial nitric oxide synthase (eNOS) upregulation.
  • Retrospective data suggest long-term statin use reduces stroke risk and improves outcomes.
  • Statin discontinuation may cause a rebound effect, decreasing NO production and impairing vascular function.

Conclusions:

  • Statins provide cerebrovascular protection through both cholesterol-lowering and pleiotropic mechanisms.
  • Upregulation of eNOS and improved NO bioavailability are key vasculoprotective actions of statins.
  • Sudden withdrawal of statin therapy can negatively impact vascular health and increase risks in patients with vascular disease.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...